Edgewise Therapeutics (EWTX) Treasury Shares (2020 - 2025)

Edgewise Therapeutics (EWTX) has 5 years of Treasury Shares data on file, last reported at $1.3 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 99.36% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (up 99.36% YoY), and the FY2025 full-year result was $1.3 million, up 99.36% from the prior year.
• Treasury Shares grew to $1.3 million in Q4 2025, from $639516.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.3 million in Q4 2025 to a low of $177871.0 in Q4 2023.
• A 4-year average of $589978.5 and a median of $453545.5 in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares slumped 33.52% in 2023 and surged 259.54% in 2024, its largest moves.
• Tracing EWTX's Treasury Shares over 4 years: stood at $267575.0 in 2022, then tumbled by 33.52% to $177871.0 in 2023, then surged by 259.54% to $639516.0 in 2024, then soared by 99.36% to $1.3 million in 2025.
• Business Quant data shows EWTX's Treasury Shares at $1.3 million in Q4 2025, $639516.0 in Q4 2024, and $177871.0 in Q4 2023.